Literature DB >> 30816623

Illicit drug use and acute kidney injury in patients admitted to hospital with rhabdomyolysis.

Corinne Lau Hing Yim1, Elena W W Wong1, Lucy J Jellie1, Andy K H Lim1,2.   

Abstract

BACKGROUND: Severe rhabdomyolysis is associated with acute kidney injury, but it is unclear if patients developing rhabdomyolysis after illicit drug use have a higher risk of acute kidney injury compared to other causes. AIMS: To provide a descriptive analysis of patients admitted with rhabdomyolysis, with a focus on illicit drug use, and to determine if illicit drug use was an independent predictor for acute kidney injury or renal replacement therapy.
METHODS: We conducted a 5-year cohort study of patients admitted to Monash Health, a tertiary referral hospital network. We identified adult patients with muscle injury from ICD-10 AM codes, serum creatine kinase level greater than 1000 U/mL, and a clinical history consistent with rhabdomyolysis. We determined the prevalence and type of illicit drug involved and determined the association between illicit drug use and renal outcomes by logistic regression.
RESULTS: Of 643 patients, illicit drug use was identified in 12%. Acute kidney injury developed in 51%, and 5% required renal replacement therapy. Compared to the rest of the cohort, patients who used illicit drugs were younger and had higher peak serum creatine kinase, and developed a higher severity of acute kidney injury. In multivariable analysis, the factors associated with acute kidney injury were illicit drug use, peak creatine kinase, cardiovascular disease, concurrent sepsis and a clinically-evident pressure injury. Chronic kidney disease and need for fasciotomy were additional risk factors for renal replacement therapy.
CONCLUSIONS: Illicit drug use was associated with acute kidney injury and renal replacement therapy independent of creatine kinase levels.
© 2019 Royal Australasian College of Physicians.

Entities:  

Keywords:  acute kidney injury; hospitalisation; illicit drug use; renal replacement therapy; rhabdomyolysis

Mesh:

Substances:

Year:  2019        PMID: 30816623     DOI: 10.1111/imj.14266

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  6 in total

Review 1.  From quail to earthquakes and human conflict: a historical perspective of rhabdomyolysis.

Authors:  Mirna Aleckovic-Halilovic; Mirha Pjanic; Enisa Mesic; Joshua Storrar; Alexander Woywodt
Journal:  Clin Kidney J       Date:  2020-05-22

2.  Chronic Kidney Disease from Polyvinylpyrrolidone Deposition in Persons with Intravenous Drug Use.

Authors:  Ida V Stalund; Heidi Grønseth; Finn P Reinholt; Einar Svarstad; Hans-Peter Marti; Sabine Leh
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-16       Impact factor: 8.237

3.  Causes and outcome of rhabdomyolysis in patients admitted to medical wards in the Prince of Wales Hospital.

Authors:  Weiwei Zeng; Brian Tomlinson
Journal:  Ann Transl Med       Date:  2021-08

4.  Epidemiology and the Impact of Acute Kidney Injury on Outcomes in Patients with Rhabdomyolysis.

Authors:  Chien-Wen Yang; Si Li; Yishan Dong; Nitpriya Paliwal; Yichen Wang
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

5.  A Cross-Sectional Study of the Relationship between Serum Creatine Kinase and Liver Biochemistry in Patients with Rhabdomyolysis.

Authors:  Andy K H Lim; Chitherangee Arumugananthan; Corinne Lau Hing Yim; Lucy J Jellie; Elena W W Wong; Ralph K Junckerstorff
Journal:  J Clin Med       Date:  2019-12-28       Impact factor: 4.241

Review 6.  Abnormal liver function tests associated with severe rhabdomyolysis.

Authors:  Andy Kh Lim
Journal:  World J Gastroenterol       Date:  2020-03-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.